Bhoomi Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 10-12-2024
- Paid Up Capital ₹ 2.50 M
as on 10-12-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.55 Cr
as on 10-12-2024
- Revenue 31.95%
(FY 2019)
- Profit -9.28%
(FY 2019)
- Ebitda -106.09%
(FY 2019)
- Net Worth 5.47%
(FY 2019)
- Total Assets 47.63%
(FY 2019)
About Bhoomi Nutraceuticals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.55 Cr.
Aatish Salunke and Jyoti Salunke serve as directors at the Company.
- CIN/LLPIN
U01119MH2006PTC164888
- Company No.
164888
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalna, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bhoomi Nutraceuticals Private Limited offer?
Bhoomi Nutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Digestive System Drugs & Medicines, Digestive Drugs, Medicinal Plant, Mucuna Pruriens, Ayurvedic Digestive Medicine, Ayurvedic Constipation Tablets Capsules.
Who are the key members and board of directors at Bhoomi Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aatish Salunke  | Director | 25-Sep-2006 | Current |
| Jyoti Salunke | Director | 25-Sep-2006 | Current |
Financial Performance of Bhoomi Nutraceuticals.
Bhoomi Nutraceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 31.95% increase. The company also saw a slight decrease in profitability, with a 9.28% decrease in profit. The company's net worth moved up by a moderate rise of 5.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhoomi Nutraceuticals?
In 2019, Bhoomi Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Aug 2016 | ₹1.55 Cr | Open |
How Many Employees Work at Bhoomi Nutraceuticals?
Unlock and access historical data on people associated with Bhoomi Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhoomi Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhoomi Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
